An award-winning researcher and founder of a biotech company based in Ireland has retracted four papers and corrected another.
In the last few weeks, Therese Kinsella — a professor at the University of College of Dublin (UCD) — has issued a correction and three retractions in the Journal of Biological Chemistry (JBC) of papers dating back to 2001, and retracted a 2012 paper in the Journal of Lipid Research.
The retraction notices describe image manipulations, but add that the authors stand by the results. The corrected paper discloses a “possible duplication,” and presents replicated data.
Kinsella is the founder and Chief Scientific Officer of ATXA Therapeutics Limited, a UCD spinoff developing drugs for pulmonary arterial hypertension which recently secured €2.5 million in public funding. Most of her retracted papers investigate the molecular biology of prostacyclin, a synthetic form of which is used to treat pulmonary arterial hypertension.
Continue reading Researcher and biotech founder in Ireland issues four retractions